ABSTRACT

The premature termination of one component of the US Women’s Health Initiative (WHI) study of the effects of hormone replacement therapy (HRT), in July 2002, has led to extensive debate in the field and in the public media1. This statement by the National Osteoporosis Society (NOS) seeks to clarify the view of the NOS Council members.